Lemaitre Vascular (LMAT) Total Current Liabilities (2010 - 2026)
Lemaitre Vascular (LMAT) reported Total Current Liabilities of $33.4 million for Q1 2026, up 34.85% year-over-year from $24.7 million in Q1 2025, and down 8.13% quarter-over-quarter from $36.3 million in Q4 2025.
Lemaitre Vascular (LMAT) Total Current Liabilities (2010 - 2026) Analysis & Trends
Lemaitre Vascular (LMAT) has 17 years of Total Current Liabilities data on file, last reported at $33.4 million in Q1 2026.
- Total Current Liabilities for Q1 2026 came in at $33.4 million, up 34.85% year-over-year; the trailing twelve-month figure through Mar 2026 was $33.4 million (up 34.85% YoY), and the FY2025 annual result was $36.3 million, up 18.68% from the prior year.
- Total Current Liabilities declined to $33.4 million in Q1 2026 per LMAT's latest filing, from $36.3 million in the prior quarter.
- Over five years, Total Current Liabilities peaked at $36.3 million in Q4 2025 and troughed at $18.3 million in Q1 2022.
- A 5-year average of $27.6 million and a median of $26.8 million in 2024 frame the typical range for Total Current Liabilities.
- The sharpest annual moves came in 2022 and 2026: Total Current Liabilities dropped 18.09% in 2022, then soared 34.85% in 2026.
- A 5-year view of Total Current Liabilities shows it stood at $25.3 million in 2022, then rose by 17.96% to $29.9 million in 2023, then increased by 2.44% to $30.6 million in 2024, then gained by 18.68% to $36.3 million in 2025, then fell by 8.13% to $33.4 million in 2026.
- Business Quant data shows LMAT's Total Current Liabilities at $33.4 million in Q1 2026, $36.3 million in Q4 2025, and $33.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 1.91 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 8.51 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 2.54 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 1.35 Bn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 674.00 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 3.35 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 1.80 Bn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 1.91 Bn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 3.69 Bn |
| 10 | Lemaitre Vascular | 2.12 Bn | 1.75 Bn | 48.40 Mn | 33.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 33.37 Mn |
| Dec 31, 2025 | 36.32 Mn |
| Sep 30, 2025 | 33.29 Mn |
| Jun 30, 2025 | 30.82 Mn |
| Mar 31, 2025 | 24.75 Mn |
| Dec 31, 2024 | 30.61 Mn |
| Sep 30, 2024 | 29.34 Mn |
| Jun 30, 2024 | 25.45 Mn |
| Mar 31, 2024 | 26.81 Mn |
| Dec 31, 2023 | 29.88 Mn |
| Sep 30, 2023 | 29.03 Mn |
| Jun 30, 2023 | 25.86 Mn |
| Mar 31, 2023 | 23.90 Mn |
| Dec 31, 2022 | 25.33 Mn |
| Sep 30, 2022 | 23.44 Mn |
| Jun 30, 2022 | 23.41 Mn |
| Mar 31, 2022 | 18.27 Mn |
| Dec 31, 2021 | 21.81 Mn |
| Sep 30, 2021 | 22.11 Mn |
| Jun 30, 2021 | 21.48 Mn |